Nanotechnology in emerging liquid biopsy applications

Nano Converg. 2021 May 2;8(1):13. doi: 10.1186/s40580-021-00263-w.

Abstract

Liquid biopsy is considered as the most attractive alternative to traditional tissue biopsies. The major advantages of this approach lie in the non-invasive procedure, the rapidness of sample collection and the potential for early cancer diagnosis and real-time monitoring of the disease and the treatment response. Nanotechnology has dynamically emerged in a wide range of applications in the field of liquid biopsy. The benefits of using nanomaterials for biosensing include high sensitivity and detectability, simplicity in many cases, rapid analysis, the low cost of the analysis and the potential for portability and personalized medicine. The present paper reports on the nanomaterial-based methods and biosensors that have been developed for liquid biopsy applications. Most of the nanomaterials used exhibit great analytical performance; moreover, extremely low limits of detection have been achieved for all studied targets. This review will provide scientists with a comprehensive overview of all the nanomaterials and techniques that have been developed for liquid biopsy applications. A comparison of the developed methods in terms of detectability, dynamic range, time-length of the analysis and multiplicity, is also provided.

Keywords: Carbon dots; Circulating tumor DNA; Circulating tumor cells; Exosomes; GO; Gold nanoparticles; Graphene oxide; MiRNA; Nanomaterials; Nanoparticles; Quantum dots.

Publication types

  • Review